Hemoglobin A1c (HbA1c)

A lab reality check before anyone panics over a tenth of a point: the NIDDK notes that an HbA1c reported as 6.8% on one draw can come back anywhere between 6.4 and 7.2 on a repeat. The gap between a 5.6 and a 5.8 feels enormous from inside a patient portal. Analytically, it may not exist.

This blood test needs no fasting, which surprises people who starved themselves before the draw. There is nothing to fast for: the value was set by the past three months, and breakfast can't reach it. If your lab asked you to fast, the instruction was for other tests on the same order.

The memory isn't evenly spread across its three months, either. Because red cells of every age circulate together, the NIDDK notes that the past 30 days influence the result more than either month before. Recent behavior counts extra, exactly like the credit score: six genuinely consistent weeks show up in the number. One careful weekend does not.

This is also why HbA1c and fasting glucose can disagree, and why the disagreement means something. Fasting glucose is a snapshot of one morning; HbA1c includes every after-dinner spike the snapshot never sees. A normal fasting result next to an elevated HbA1c often describes someone whose sugar behaves at 8 a.m. and misbehaves the rest of the day. When the two point in different directions, doctors treat that as a reason to look closer, sometimes with an oral glucose tolerance test, rather than picking the friendlier number. The HbA1c vs fasting glucose comparison takes the two head to head.

In the 5.7–6.4 band, the usual story is early insulin resistance: the body still controls sugar, but it's working harder to do it. Pairing the result with a fasting insulin measurement often says more than HbA1c alone, which is why the two travel together on testing panels; the insulin vs HbA1c comparison explains what each adds. The same metabolic picture usually shows up across the lipid panel too: a high triglyceride level paired with a low HDL is one of its earliest signatures. This stage matters because it's reversible. NICE built its entire type 2 prevention guideline around exactly this band, on the logic that structured changes to food, activity, and weight work best before the diagnosis, not after. Chromium takes part in insulin signaling in the laboratory, which is why it is so often marketed for blood sugar, yet chromium supplements have shown at best a small, inconsistent effect on glucose and a chromium blood level can't reliably gauge status.

At 6.5% and above, confirmed by a second test, the territory is diabetes. To make the number concrete, many reports translate it into an estimated average glucose: an HbA1c of 7% corresponds to an average near 154 mg/dL, by a formula the American Diabetes Association derived from thousands of paired glucose measurements. It answers the question patients actually ask ("so what is my sugar running day to day?") in units a glucose meter speaks. Where HbA1c captures months of average glucose, beta-hydroxybutyrate is the acute signal that ketones are rising and is the blood test used to check for ketoacidosis.

Strictly speaking, HbA1c doesn't measure sugar. It measures sugar's fingerprints on red blood cells, then assumes those cells live a standard three months. When that assumption fails, the score fails with it, and the direction depends on what the red cells are doing:

• Iron deficiency pushes it up. Red cells in someone with low ferritin live longer than usual and collect extra glucose coating, and the NIDDK lists iron-deficiency anemia among the causes of falsely high results. A flagged HbA1c in a long-time blood donor or a woman with heavy periods deserves an iron check before a diabetes conversation.
• A young red-cell population pushes it down. Recent blood loss or donation, hemolytic anemia, erythropoietin treatment, and dialysis all fill the bloodstream with cells too new to carry three months of history.
• Inherited hemoglobin variants can confuse the assay itself. Sickle cell trait and similar variants, most common in people with African, Mediterranean, or Southeast Asian ancestry, can skew results either way; the NIDDK maintains a dedicated guide on testing in these situations.
• Pregnancy (second and third trimester), kidney failure, and liver disease shift the number too, which is part of why pregnancy diabetes screening relies on glucose tests instead.

When HbA1c can't be trusted, medicine pulls a different file. Fructosamine and glycated albumin read the same story off blood proteins over the previous two to three weeks, and a plain glucose measurement makes no assumptions about red cells at all. When a red-cell or albumin condition makes one marker unreliable, clinicians may pair A1C with a shorter-window alternative like glycated albumin, which reflects roughly the past two to three weeks. If your HbA1c has never matched what your meter shows, this mismatch is worth raising with your doctor explicitly.

HbA1c anchors the diabetes panel, where it reads alongside fasting glucose and often insulin; the diabetes panel guide walks through the full lineup. But its real character is longitudinal. A 5.9 that was 5.4 last year and 5.1 the year before is a trend asking for attention while there is still plenty of runway. A 5.9 that has sat still for a decade is just your number. The test already averages three months on its own; stack a few years of results and the direction tells you more than any single value.